Windtree Therapeutics Inc (WINT)
0.5093
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.5091
0.00 (0.00%)
Pre-Market: 08:53
Windtree Therapeutics Enterprise Value: 0.5065M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.5065M |
| November 20, 2024 | 0.5071M |
| November 19, 2024 | 0.4818M |
| November 18, 2024 | 0.4915M |
| November 15, 2024 | 0.4862M |
| November 14, 2024 | 0.4979M |
| November 13, 2024 | 0.5174M |
| November 12, 2024 | 0.5382M |
| November 11, 2024 | 0.5601M |
| November 08, 2024 | 0.5513M |
| November 07, 2024 | 0.5665M |
| November 06, 2024 | 0.568M |
| November 05, 2024 | 0.6155M |
| November 04, 2024 | 0.6193M |
| November 01, 2024 | 0.6318M |
| October 31, 2024 | 0.6213M |
| October 30, 2024 | 0.6449M |
| October 29, 2024 | 0.6911M |
| October 28, 2024 | 0.7199M |
| October 25, 2024 | 0.7162M |
| October 24, 2024 | 0.7026M |
| October 23, 2024 | 0.7336M |
| October 22, 2024 | 0.7353M |
| October 21, 2024 | 0.8383M |
| October 18, 2024 | 0.7456M |
| Date | Value |
|---|---|
| October 17, 2024 | 0.791M |
| October 16, 2024 | 0.614M |
| October 15, 2024 | 0.5957M |
| October 14, 2024 | 0.6075M |
| October 11, 2024 | 0.6282M |
| October 10, 2024 | 0.6205M |
| October 09, 2024 | 0.6489M |
| October 08, 2024 | 0.7495M |
| October 07, 2024 | 0.8443M |
| October 04, 2024 | 0.862M |
| October 03, 2024 | 0.8561M |
| October 02, 2024 | 1.057M |
| October 01, 2024 | 1.430M |
| September 30, 2024 | 1.620M |
| September 27, 2024 | 1.726M |
| September 26, 2024 | 1.809M |
| September 25, 2024 | 1.922M |
| September 24, 2024 | 2.135M |
| September 23, 2024 | 2.235M |
| September 20, 2024 | 2.058M |
| September 19, 2024 | 2.123M |
| September 18, 2024 | 2.170M |
| September 17, 2024 | 2.099M |
| September 16, 2024 | 2.081M |
| September 13, 2024 | 2.081M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.288M
Minimum
Sep 25 2023
167.50M
Maximum
Dec 06 2019
32.43M
Average
5.912M
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals Inc | 1.671B |
| AIM ImmunoTech Inc | 9.017M |
| Perspective Therapeutics Inc | -63.40M |
| Protalix BioTherapeutics Inc | 94.82M |
| Armata Pharmaceuticals Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.02M |
| Total Expenses (Quarterly) | 11.45M |
| EPS Diluted (Quarterly) | -20.91 |
| Earnings Yield | -5.44K% |
| Normalized Earnings Yield | -1.149M |